3Infection and the Implant: From Pocket Infection to Biofilm

FSuperficial versus deep infection

Infection over an implant exists on a spectrum: a superficial cellulitis or stitch abscess in the skin is a different problem from a deep infection seated on the device itself. Superficial infection involves the soft tissue but spares the hardware, and usually responds to a course of antibiotics with local care. Deep or device infection reaches the receiver pocket and the implant surface, where antibiotics struggle to reach effective concentrations against organisms shielded on the hardware. The clinical art is telling the two apart early, because a deep infection treated as if it were superficial simply smoulders and recurs.[2004][2004]

TBiofilm: why the implant changes the rules

Bacteria that settle on an implant surface secrete a slimy extracellular matrix and switch into a sessile community called a biofilm, fundamentally different from free-floating planktonic bacteria. Within a biofilm organisms are physically shielded and metabolically slowed, making them dramatically more tolerant of antibiotics and of the host immune system than the same bacteria growing freely. Investigators have recovered microorganisms and biofilm matrix directly from the surfaces of infected and extruding cochlear implants, which explains why these infections relapse the moment antibiotics stop. Once a mature biofilm coats the device, clearing the infection without removing the colonised hardware becomes very difficult, which is the central reason some implants ultimately have to come out.[2004][2004]

TThe usual suspects and the management ladder

The commonest organisms reflect skin and ear flora: Staphylococcus aureus, including methicillin-resistant MRSA strains, and Pseudomonas aeruginosa especially when there is otorrhoea or a perforation. Management is conservative-first: targeted antibiotics guided by culture, and surgical debridement of devitalised tissue to reduce the bacterial and biofilm burden, aiming to salvage the device. Many soft-tissue and pocket infections can indeed be salvaged this way, and the implant is preserved. Device removal becomes unavoidable when infection is biofilm-entrenched on the hardware, when the device is exposed, or when aggressive medical and surgical therapy repeatedly fails; the device is then explanted, the site healed, and reimplantation considered later.[2004][2004]

CMeningitis, otitis media and the case for vaccination

An implanted child gets ordinary acute otitis media, but the electrode crosses from the middle ear into the cochlea, creating a potential pathway from a middle-ear infection toward the meninges. A landmark investigation of over four thousand implanted children found the rate of pneumococcal meningitis was more than thirty times that of unimplanted age-matched children, with a particular positioner-type electrode implicated. Streptococcus pneumoniae is the dominant meningitis organism, so pneumococcal vaccination is recommended for implant recipients, alongside prompt and aggressive treatment of any acute otitis media. Prevention is layered: vaccination, packing the cochleostomy with soft tissue at surgery, less traumatic atraumatic electrodes, treating ear infections early, and family education about red-flag symptoms.[2003][2008]